Statistics for Biotalys NV (id:393 BTLS)
Valuation metrics
Market cap
106.73M
Enterprise value
80.83M
Trailing P/E (ttm)
-4.80
Forward P/E
-7.00
PEG ratio
-7.00
Price/Sales (ttm)
Price/Book (mrq)
4.60
Enterprise Value/Revenue
Enterprise Value/EBITDA
-5.36
Overview
Shares outstanding
37.46M
Float
9.20M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
14.45K
Average volume (90 days)
Price summary
52-Week low
2.50
52-Week high
5.00
52-Week change
-50.64%
Beta
3.00
50-Day moving average
3.10
200-Day moving average
3.03
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
June 30, 2021
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-27.07%
Return on equity
-59.66%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-15,094,000.00
Net income to common (ttm)
-16,335,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
14.68M
Total cash per share (mrq)
3.00
Total debt (mrq)
5.48M
Total Debt/Equity (mrq)
28.02
Current ratio (mrq)
388.20%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-16,294,000.00
Levered free cash flow (LFCF)
-11,381,500.00